VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Search Videos by Topic or Participant
Browse by Series:

Safety Concerns With Breakthrough Cancer Pain Treatments

Panelists: Charles E. Argoff, MD, Albany Medical Center; Jeri L. Ashley, RN, Baptist Memorial;Vitaly Gordin, MD, Penn State Hershey; Jeffrey A. Gudin, M
Published: Friday, Jun 20, 2014
For High-Definition, Click
Like many analgesics, transmucosal immediate-release fentanyl (TIRF) products can be associated with adverse events. Concerns over these unintended consequences are often enhanced when treating breakthrough cancer pain, since patients with cancer can be frail and are often elderly, notes Vitaly Gordin, MD.

For patients taking TIRF products, the main concerns are excessive sedation with respiratory suppression and constipation. Additionally, patients could be unstable when taking analgesics, resulting in falls and fractures. These concerns should be weighed when determining the appropriate dose, Gordin notes.

In general, TIRF products should be stored in a lock box and kept away from children and pets, notes Jeri L. Ashley, RN. Additionally, patients should avoid driving while using analgesics.  
Slider Left
Slider Right
For High-Definition, Click
Like many analgesics, transmucosal immediate-release fentanyl (TIRF) products can be associated with adverse events. Concerns over these unintended consequences are often enhanced when treating breakthrough cancer pain, since patients with cancer can be frail and are often elderly, notes Vitaly Gordin, MD.

For patients taking TIRF products, the main concerns are excessive sedation with respiratory suppression and constipation. Additionally, patients could be unstable when taking analgesics, resulting in falls and fractures. These concerns should be weighed when determining the appropriate dose, Gordin notes.

In general, TIRF products should be stored in a lock box and kept away from children and pets, notes Jeri L. Ashley, RN. Additionally, patients should avoid driving while using analgesics.  
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Pediatric Hepatic Veno-Occlusive Disease: Integrating Novel Therapeutic Strategies to Overcome Post-Transplant ObstaclesMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x